MPT MEDICAL PROPERTIES TRUST INC
Real Estate Investment Trusts · NYSE · SEC CIK 1287865 · Fiscal year ends 12/31
Financial factors as of 2026-03-31 (2026Q1), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 | 2024Q22024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $252.06M | $270.34M | $237.52M | $240.36M | $223.80M | $231.84M | $225.83M | $266.56M |
| Cost of revenue | $97.33M | $11.43M | -$22.29M | $19.76M | $81.41M | $21.13M | $7.84M | $4.32M |
| SG&A expense | $32.20M | $24.59M | $37.73M | $26.20M | $41.91M | $28.49M | $36.62M | $35.33M |
| Interest expense | $133.33M | $132.46M | $132.40M | $129.71M | $115.80M | $101.47M | $106.24M | $101.43M |
| Pretax income | $285,000 | $26.10M | -$66.58M | -$88.27M | -$108.58M | -$402.76M | -$791.90M | -$305.10M |
| Income tax | -$32.82M | $8.51M | $10.87M | $9.80M | $9.44M | $9.56M | $9.03M | $14.56M |
| Net income | $32.83M | $17.31M | -$77.73M | -$98.36M | -$118.28M | -$412.85M | -$801.16M | -$320.63M |
| EPS (basic) | 0.05 | — | -0.13 | -0.16 | -0.20 | — | -1.34 | -0.54 |
| EPS (diluted) | 0.05 | — | -0.13 | -0.16 | -0.20 | — | -1.34 | -0.54 |
| Dividends declared per share | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.30 |
| Weighted avg. shares (diluted) | 597.72M | — | 601.14M | 600.81M | 600.59M | — | 600.23M | 600.06M |
| Balance sheet | ||||||||
| Cash & equivalents | $425.00M | $540.86M | $396.58M | $509.83M | $673.48M | $332.33M | $275.62M | $606.55M |
| Total assets | $14.76B | $15.00B | $14.92B | $15.15B | $14.85B | $14.29B | $15.24B | $16.19B |
| Long-term debt | $9.66B | $9.70B | $9.62B | $9.65B | $9.47B | $8.85B | $9.22B | $9.37B |
| Total debt | $9.66B | $9.70B | $9.62B | $9.65B | $9.47B | $8.85B | $9.22B | $9.37B |
| Total liabilities | $10.22B | $10.39B | $10.26B | $10.32B | $10.09B | $9.46B | $9.80B | $10.00B |
| Shareholders' equity | $4.54B | $4.61B | $4.66B | $4.83B | $4.76B | $4.83B | $5.44B | $6.19B |
| Net debt | $9.24B | $9.16B | $9.22B | $9.14B | $8.79B | $8.52B | $8.94B | $8.76B |
| Shares outstanding | 597.72M | 597.01M | 601.14M | 600.81M | 600.60M | 600.40M | 600.23M | 600.06M |
| Cash flow statement | ||||||||
| Operating cash flow | -$14.26M | $160.06M | $18.57M | $51.75M | $384,000 | $76.69M | $59.20M | $35.26M |
| Investing cash flow | -$76.78M | -$7.87M | -$95.14M | -$72.32M | -$89.42M | $91.74M | $143.75M | $1.20B |
| Financing cash flow | -$23.22M | -$8.98M | -$34.46M | -$154.80M | $426.32M | -$99.81M | -$548.13M | -$853.52M |
| Depreciation & amortization | $73.35M | $69.67M | $66.99M | $66.72M | $65.43M | $66.20M | $204.88M | $102.24M |
| Stock-based compensation | $573,000 | -$5.12M | $12.34M | $857,000 | $17.66M | $2.40M | $14.43M | $8.52M |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.